Ardent Health, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
8.93
+0.05 (0.56%)
Dec 3, 2025, 4:00 PM EST - Market closed
Ardent Health Stock Forecast
Stock Price Forecast
The 10 analysts that cover Ardent Health stock have a consensus rating of "Buy" and an average price target of $14.7, which forecasts a 64.61% increase in the stock price over the next year. The lowest target is $10 and the highest is $22.
Price Target: $14.7 (+64.61%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Ardent Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 7 | 7 | 7 | 7 | 6 | 4 |
| Hold | 3 | 2 | 2 | 1 | 2 | 3 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 12 | 12 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold Maintains $15 → $12 | Hold | Maintains | $15 → $12 | +34.38% | Nov 24, 2025 |
| Mizuho | Mizuho | Buy Maintains $20 → $13 | Buy | Maintains | $20 → $13 | +45.58% | Nov 18, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $18 → $15 | Strong Buy | Maintains | $18 → $15 | +67.97% | Nov 18, 2025 |
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 17, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $21 → $16 | Buy | Maintains | $21 → $16 | +79.17% | Nov 14, 2025 |
Financial Forecast
Revenue This Year
6.47B
from 5.97B
Increased by 8.45%
Revenue Next Year
6.75B
from 6.47B
Increased by 4.37%
EPS This Year
1.11
from 1.58
Decreased by -29.88%
EPS Next Year
1.34
from 1.11
Increased by 20.69%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 6.7B | 7.0B | ||
| Avg | 6.5B | 6.8B | ||
| Low | 6.2B | 6.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 12.4% | 8.6% | ||
| Avg | 8.4% | 4.4% | ||
| Low | 3.8% | -2.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.01 | 1.64 | |
| Avg | 1.11 | 1.34 | |
| Low | 0.83 | 1.07 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 26.9% | 47.8% | |
| Avg | -29.9% | 20.7% | |
| Low | -47.3% | -3.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.